Skip to main content

. 1989;87:445–462.

Bilateral intracavernous carotid aneurysms presenting as pseudo-ocular myasthenia gravis.

J S Mindel ¹, J Z Charney ¹

PMCID: PMC1298554 PMID: 2562526

445

Images in this article

FIGURE 1
on p.447

FIGURE 2
on p.448

FIGURE 3
on p.449

FIGURE 4
on p.450

FIGURE 5
on p.451

FIGURE 6
on p.453

FIGURE 7
on p.454

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Argov Z., Mastaglia F. L. Drug therapy: Disorders of neuromuscular transmission caused by drugs. N Engl J Med. 1979 Aug 23;301(8):409–413. doi: 10.1056/NEJM197908233010805. [DOI] [PubMed] [Google Scholar]
Ashizawa T. False positive anti-acetylcholine receptor antibodies in motorneurone disease. Lancet. 1986 May 31;1(8492):1272–1272. doi: 10.1016/s0140-6736(86)91408-x. [DOI] [PubMed] [Google Scholar]
Bartleson J. D., Trautmann J. C., Sundt T. M., Jr Minimal oculomotor nerve paresis secondary to unruptured intracranial aneurysm. Arch Neurol. 1986 Oct;43(10):1015–1020. doi: 10.1001/archneur.1986.00520100033011. [DOI] [PubMed] [Google Scholar]
Bever C. T., Jr, Aquino A. V., Penn A. S., Lovelace R. E., Rowland L. P. Prognosis of ocular myasthenia. Ann Neurol. 1983 Nov;14(5):516–519. doi: 10.1002/ana.410140504. [DOI] [PubMed] [Google Scholar]
Boghen D., Chartrand J. P., Laflamme P., Kirkham T., Hardy J., Aube M. Primary aberrant third nerve regeneration. Ann Neurol. 1979 Nov;6(5):415–418. doi: 10.1002/ana.410060507. [DOI] [PubMed] [Google Scholar]
Carlson H. E., Chang R. J., Meyer N. V., Lu K. H., Judd H. L. Effect of cimetidine on serum prolactin in normal women and patients with hyperprolactinaemia. Clin Endocrinol (Oxf) 1981 Nov;15(5):491–498. doi: 10.1111/j.1365-2265.1981.tb00693.x. [DOI] [PubMed] [Google Scholar]
Cox T. A., Wurster J. B., Godfrey W. A. Primary aberrant oculomotor regeneration due to intracranial aneurysm. Arch Neurol. 1979 Sep;36(9):570–571. doi: 10.1001/archneur.1979.00500450064012. [DOI] [PubMed] [Google Scholar]
FLORIN R. E. Bilateral symmetrical aneurysms of the internal carotid arteries with spontaneous carotid cavernous fistula. Calif Med. 1958 Nov;89(5):352–355. [PMC free article] [PubMed] [Google Scholar]
Genkins G., Papatestas A. E., Horowitz S. H., Kornfield P. Studies in myasthenia gravis: early thymectomy. Electrophysiologic and pathologic correlations. Am J Med. 1975 Apr;58(4):517–524. doi: 10.1016/0002-9343(75)90125-4. [DOI] [PubMed] [Google Scholar]
Hochman M. S. Ocular myasthenia. Multiple recurrences and spontaneous remissions. JAMA. 1982 Jan 1;247(1):62–62. doi: 10.1001/jama.247.1.62. [DOI] [PubMed] [Google Scholar]
Kaeser H. E. Drug-induced myasthenic syndromes. Acta Neurol Scand Suppl. 1984;100:39–47. [PubMed] [Google Scholar]
Kupersmith M. J., Berenstein A., Choi I. S., Ransohoff J., Flamm E. S. Percutaneous transvascular treatment of giant carotid aneurysms: neuro-ophthalmologic findings. Neurology. 1984 Mar;34(3):328–335. doi: 10.1212/wnl.34.3.328. [DOI] [PubMed] [Google Scholar]
LOGUE V. Saccular aneurysms of the internal carotid artery in the cavernous sinus occurring bilaterally. Br J Surg. 1951 Sep;39(154):181–182. doi: 10.1002/bjs.18003915413. [DOI] [PubMed] [Google Scholar]
Lane R. J., Mastaglia F. L. Drug-induced myopathies in man. Lancet. 1978 Sep 9;2(8089):562–566. doi: 10.1016/s0140-6736(78)92894-5. [DOI] [PubMed] [Google Scholar]
Lecky B. R., Morgan-Hughes J. A., Landon D. N., Murray N. M. Intercostal muscle acetylcholine receptors in longstanding ocular myasthenia. Lancet. 1980 Dec 13;2(8207):1311–1312. doi: 10.1016/s0140-6736(80)92387-9. [DOI] [PubMed] [Google Scholar]
Locke W. Control of anterior pituitary function. Arch Intern Med. 1978 Oct;138(10):1541–1545. [PubMed] [Google Scholar]
MULDER D. W., LAMBERT E. H., EATON L. M. Myasthenic syndrome in patients with amyotrophic lateral sclerosis. Neurology. 1959 Oct;9:627–631. doi: 10.1212/wnl.9.10.627. [DOI] [PubMed] [Google Scholar]
Mastaglia F. I., Black J. I., Collins D. W., Dawkins R. I. Saccadic velocities in diagnosis of myasthenia gravis. Lancet. 1977 Jul 9;2(8028):83–83. doi: 10.1016/s0140-6736(77)90078-2. [DOI] [PubMed] [Google Scholar]
Mindel J. S., Sachdev V. P., Kline L. B., Sivak M. A., Bergman D. A., Yang W. C., Choi I. S., Huang Y. P. Bilateral intracavernous carotid aneurysms mimicking a prolactin-secreting pituitary tumor. Surg Neurol. 1983 Feb;19(2):163–167. doi: 10.1016/0090-3019(83)90417-2. [DOI] [PubMed] [Google Scholar]
Osher R. H., Griggs R. C. Orbicularis fatigue: the 'peek' sign of myasthenia gravis. Arch Ophthalmol. 1979 Apr;97(4):677–679. doi: 10.1001/archopht.1979.01020010333009. [DOI] [PubMed] [Google Scholar]
Peiris J. B., Ross Russell R. W. Giant aneurysms of the carotid system presenting as visual field defect. J Neurol Neurosurg Psychiatry. 1980 Dec;43(12):1053–1064. doi: 10.1136/jnnp.43.12.1053. [DOI] [PMC free article] [PubMed] [Google Scholar]
Scadding G. K., Havard C. W. Pathogenesis and treatment of myasthenia gravis. Br Med J (Clin Res Ed) 1981 Oct 17;283(6298):1008–1012. doi: 10.1136/bmj.283.6298.1008. [DOI] [PMC free article] [PubMed] [Google Scholar]
Seybold M. E. Myasthenia gravis. A clinical and basic science review. JAMA. 1983 Nov 11;250(18):2516–2521. doi: 10.1001/jama.250.18.2516. [DOI] [PubMed] [Google Scholar]
Swift T. R. Disorders of neuromuscular transmission other than myasthenia gravis. Muscle Nerve. 1981 Jul-Aug;4(4):334–353. doi: 10.1002/mus.880040410. [DOI] [PubMed] [Google Scholar]

ACTIONS

PDF (5.1 MB)

RESOURCES